(0) NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. Calgary, Alberta--(Newsfile Corp. - May 29, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VFO.F) ("Hemostemix" or the "Company") is pleased to announce that it has obtained preliminary approval from the TSX Venture Exchange to close a $2,500,000 convertible debenture order from a director for Debenture Units priced at $0.40 per Unit as detailed below. On May 28, 2021, Hemostemix filed its Financial Statements and Management Discussion and Analysis for the period ending March 31, 2020 on S...